Full Text
Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid Trial

Abstract

Authors

M. Connolly C. Currie J. Chang

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×